Investigation of circulating metabolites associated with breast cancer risk by untargeted metabolomics: a case-control study nested within the French E3N cohort
Recommendations from the European Commission Initiative on Breast Cancer (ECIBC) for multigene testing
In the EU, including UK, 404,920 women were diagnosed with breast cancer (BC) and 98,755 died in 2018 (ECIS 2018). As BC outcomes differ across Europe, the ECIBC aimed to develop adaptable recommendations on BC prevention and diagnosis and a quality assurance scheme applicable throughout Europe.
MONITORING EPITHELIAL OVARIAN CANCER WITH QUANTITATIVE IMAGING: CORRELATION OF IMAGING WITH HISTOPATHOLOGICAL METRICS
Link to manuscript: https://www.nature.com/articles/s41416-020-01217-5.
The Covid-19 pandemic and impact on breast cancer diagnoses: what happened in England in the first half of 2020
Breast cancer is the most commonly diagnosed cancer in women in England. Data from the NHS Cancer Waiting Time team was used to examine the impact of the COVID-19 pandemic on breast cancer diagnoses in the first half of 2020. I will briefly explain the main findings and plans for further work.
Obesity and cancer- moving beyond the epidemiology to focus on intervention research Annie S. Anderson, University of Dundee
Obesity and cancer can be an emotive topic laden with guilt and a feeling of being overburdened. It has been described as the “elephant in the room” but the bottom line is that it is time to move beyond epidemiology and mechanisms to open the door on interventional research.
Pathological features of 11337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events – results from the UK Sloane project